According to this systematic review of epidemiological studies, fibroid prevalence varied widely, with no consistent association across studies between observed estimates and country, methodology, and population. Fibroid incidence was higher in black than in white women independently of other risk factors, suggesting a racial predisposition. A genetic influence was confirmed also by the association with a positive family history. The association with age and menopausal status maybe interpreted in terms of varying degrees of oestrogen exposure, which could explain also the association with food additives and soybean consumption. Along this line, the "anti-oestrogenic" effect of smoking was observed only in women with low BMI. Association were observed also with reproductive factors (parity and time since last birth) and oral/injectable contraceptives.

Uterine fibroids : from observational epidemiology to clinical management / P. Vercellini, M.P. Frattaruolo. - In: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. - ISSN 1470-0328. - 124:10(2017 Sep), pp. 1513-1513. [10.1111/1471-0528.14730]

Uterine fibroids : from observational epidemiology to clinical management

P. Vercellini
Primo
;
M.P. Frattaruolo
Ultimo
2017

Abstract

According to this systematic review of epidemiological studies, fibroid prevalence varied widely, with no consistent association across studies between observed estimates and country, methodology, and population. Fibroid incidence was higher in black than in white women independently of other risk factors, suggesting a racial predisposition. A genetic influence was confirmed also by the association with a positive family history. The association with age and menopausal status maybe interpreted in terms of varying degrees of oestrogen exposure, which could explain also the association with food additives and soybean consumption. Along this line, the "anti-oestrogenic" effect of smoking was observed only in women with low BMI. Association were observed also with reproductive factors (parity and time since last birth) and oral/injectable contraceptives.
Settore MED/40 - Ginecologia e Ostetricia
set-2017
12-mag-2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
10.1111@1471-0528.14730.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 47.86 kB
Formato Adobe PDF
47.86 kB Adobe PDF Visualizza/Apri
Vercellini_et_alii_BJOG__UterineFibroids_2017.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 102.29 kB
Formato Adobe PDF
102.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/494428
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact